481 filings
8-K
ACST
Acasti Pharma Inc.
25 Sep 24
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
8:00am
DEFA14A
ACST
Acasti Pharma Inc.
6 Sep 24
Additional proxy soliciting materials
4:07pm
8-K
ACST
Acasti Pharma Inc.
16 Aug 24
Departure of Directors or Certain Officers
4:05pm
8-K
ACST
Acasti Pharma Inc.
9 Aug 24
Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
8:00am
10-Q
2024 Q1
ACST
Acasti Pharma Inc.
Quarterly report
9 Aug 24
7:30am
DEFA14A
ACST
Acasti Pharma Inc.
7 Aug 24
Additional proxy soliciting materials
4:15pm
424B3
ACST
Acasti Pharma Inc.
7 Aug 24
Prospectus supplement
4:14pm
EFFECT
ACST
Acasti Pharma Inc.
5 Aug 24
Notice of effectiveness
12:15am
S-4/A
ACST
Acasti Pharma Inc.
Registration of securities issued in business combination transactions (amended)
31 Jul 24
7:22am
3/A
ADAR1 Capital Management, LLC
11 Jul 24
Initial statement of insider ownership (amended)
11:16am
SC 13G
ADAR1 Capital Management, LLC
10 Jul 24
Acasti Pharma / ADAR1 Capital Management ownership change
9:10pm
3
ADAR1 Capital Management, LLC
9 Jul 24
Initial statement of insider ownership
8:29pm
S-4
ACST
Acasti Pharma Inc.
Registration of securities issued in business combination transactions
27 Jun 24
5:01pm
8-K
ACST
Acasti Pharma Inc.
27 Jun 24
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
4:10pm
8-K
ACST
Acasti Pharma Inc.
21 Jun 24
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
8:00am
10-K
2024 FY
ACST
Acasti Pharma Inc.
Annual report
21 Jun 24
7:30am
4/A
Carrie D'Andrea
10 May 24
Acasti Pharma / Carrie D'Andrea ownership change
4:11pm
4/A
Amresh Kumar
10 May 24
Acasti Pharma / Amresh Kumar ownership change
4:07pm
4
Carrie D'Andrea
8 May 24
Acasti Pharma / Carrie D'Andrea ownership change
7:19pm
4
Amresh Kumar
8 May 24
Acasti Pharma / Amresh Kumar ownership change
7:19pm